Paul T Quinlan insider trades: Oruka Therapeutics (ORKA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Paul reports to the SEC
Open-market buys and sales
55 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | ORKA | ↓ Sell | 9,000 | $78.53 | $707K | Direct | Oct 20, 2026 (0d) |
| Sep 21, 2026 | ORKA | ↓ Sell | 10,000 | $93.64 | $936K | Direct | Sep 21, 2026 (0d) |
| Sep 15, 2026 | ORKA | ↓ Sell | 1,039 | $95.71 | $99K | Direct | Sep 15, 2026 (0d) |
| Aug 14, 2026 | ORKA | ↓ Sell | 52,000 | $108.49 | $5.6M | Direct | Aug 14, 2026 (0d) |
| Jun 15, 2026 | ORKA | ↓ Sell | 733 | $69.69 | $51K | Direct | Jun 15, 2026 (0d) |
| Mar 16, 2026 | ORKA | ↓ Sell | 733 | $41.30 | $30K | Direct | Mar 17, 2026 (1d) |
| Jan 16, 2024 | CBAY | ↓ Sell | 5,000 | $23.58 | $118K | Direct | Jan 16, 2024 (0d) |
| Dec 15, 2023 | CBAY | ↓ Sell | 5,000 | $21.98 | $110K | Direct | Dec 15, 2023 (0d) |
| Nov 15, 2023 | CBAY | ↓ Sell | 5,000 | $17.38 | $87K | Direct | Nov 17, 2023 (2d) |
| Oct 16, 2023 | CBAY | ↓ Sell | 5,000 | $13.76 | $69K | Direct | Oct 18, 2023 (2d) |
| Sep 15, 2023 | CBAY | ↓ Sell | 53,000 | $16.87 | $894K | Direct | Sep 19, 2023 (4d) |
| Aug 15, 2023 | CBAY | ↓ Sell | 5,000 | $11.91 | $60K | Direct | Aug 16, 2023 (1d) |
| Jul 14, 2023 | CBAY | ↓ Sell | 5,000 | $11.81 | $59K | Direct | Jul 14, 2023 (0d) |
| Jun 30, 2023 | CBAY | ↓ Sell | 5,000 | $10.05 | $50K | Direct | Jun 30, 2023 (0d) |
| May 15, 2023 | CBAY | ↓ Sell | 5,000 | $10.37 | $52K | Direct | May 17, 2023 (2d) |
| Mar 9, 2017 | TVIA | ↓ Sell | 25,000 | $0.81 | $20K | Direct | Mar 13, 2017 (4d) |
| Oct 14, 2016 | TVIA | ↓ Sell | 10,000 | $2.55 | $26K | Direct | Oct 14, 2016 (0d) |
| Sep 16, 2016 | TVIA | ↓ Sell | 3,124 | $2.60 | $8K | Direct | Sep 16, 2016 (0d) |
| Sep 13, 2016 | TVIA | ↓ Sell | 1,562 | $2.74 | $4K | Direct | Sep 15, 2016 (2d) |
| Mar 10, 2016 | SZYM | ↓ Sell | 4,686 | $1.64 | $8K | Direct | Mar 14, 2016 (4d) |
| Mar 8, 2016 | SZYM | ↓ Sell | 1,562 | $1.66 | $3K | Direct | Mar 9, 2016 (1d) |
| Sep 17, 2015 | SZYM | ↓ Sell | 3,124 | $3.11 | $10K | Direct | Sep 17, 2015 (0d) |
| Mar 9, 2015 | SZYM | ↓ Sell | 9,687 | $2.69 | $26K | Direct | Mar 11, 2015 (2d) |
| Sep 9, 2014 | SZYM | ↓ Sell | 16,562 | $8.53 | $141K | Direct | Sep 11, 2014 (2d) |
| Aug 19, 2014 | SZYM | ↓ Sell | 8,500 | $9.43 | $80K | Direct | Aug 19, 2014 (0d) |
| Jul 21, 2014 | SZYM | ↓ Sell | 6,000 | $9.80 | $59K | Direct | Jul 22, 2014 (1d) |
| Jun 19, 2014 | SZYM | ↓ Sell | 6,000 | $11.99 | $72K | Direct | Jun 20, 2014 (1d) |
| May 19, 2014 | SZYM | ↓ Sell | 6,000 | $9.20 | $55K | Direct | May 19, 2014 (0d) |
| Apr 21, 2014 | SZYM | ↓ Sell | 6,000 | $11.33 | $68K | Direct | Apr 21, 2014 (0d) |
| Mar 19, 2014 | SZYM | ↓ Sell | 6,000 | $14.39 | $86K | Direct | Mar 19, 2014 (0d) |
| Mar 4, 2014 | SZYM | ↓ Sell | 3,125 | $12.21 | $38K | Direct | Mar 4, 2014 (0d) |
| Feb 24, 2014 | SZYM | ↓ Sell | 8,239 | $11.61 | $96K | Direct | Feb 24, 2014 (0d) |
| Jan 21, 2014 | SZYM | ↓ Sell | 6,000 | $10.47 | $63K | Direct | Jan 22, 2014 (1d) |
| Dec 19, 2013 | SZYM | ↓ Sell | 6,000 | $9.40 | $56K | Direct | Dec 19, 2013 (0d) |
| Nov 19, 2013 | SZYM | ↓ Sell | 6,000 | $8.41 | $50K | Direct | Nov 19, 2013 (0d) |
| Oct 21, 2013 | SZYM | ↓ Sell | 6,000 | $11.47 | $69K | Direct | Oct 21, 2013 (0d) |
| Sep 19, 2013 | SZYM | ↓ Sell | 6,000 | $10.73 | $64K | Direct | Sep 19, 2013 (0d) |
| Aug 16, 2013 | SZYM | ↓ Sell | 739 | $11.89 | $9K | Direct | Aug 16, 2013 (0d) |
| Jun 19, 2013 | SZYM | ↓ Sell | 3,000 | $12.04 | $36K | Direct | Jun 21, 2013 (2d) |
| May 20, 2013 | SZYM | ↓ Sell | 3,000 | $11.17 | $34K | Direct | May 21, 2013 (1d) |
| May 10, 2013 | SZYM | ↓ Sell | 21,000 | $10.00 | $210K | Direct | May 10, 2013 (0d) |
| Oct 12, 2012 | SZYM | ↓ Sell | 2,000 | $10.24 | $20K | Direct | Oct 12, 2012 (0d) |
| Sep 19, 2012 | SZYM | ↓ Sell | 3,000 | $11.39 | $34K | Direct | Sep 20, 2012 (1d) |
| Sep 12, 2012 | SZYM | ↓ Sell | 2,000 | $11.44 | $23K | Direct | Sep 13, 2012 (1d) |
| Aug 20, 2012 | SZYM | ↓ Sell | 3,000 | $13.17 | $40K | Direct | Aug 20, 2012 (0d) |
| Aug 13, 2012 | SZYM | ↓ Sell | 2,000 | $11.89 | $24K | Direct | Aug 13, 2012 (0d) |
| Jul 19, 2012 | SZYM | ↓ Sell | 3,000 | $13.51 | $41K | Direct | Jul 20, 2012 (1d) |
| Jul 12, 2012 | SZYM | ↓ Sell | 2,000 | $11.42 | $23K | Direct | Jul 12, 2012 (0d) |
| Jun 12, 2012 | SZYM | ↓ Sell | 2,000 | $12.23 | $24K | Direct | Jun 13, 2012 (1d) |
| May 14, 2012 | SZYM | ↓ Sell | 2,000 | $10.06 | $20K | Direct | May 14, 2012 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORKA insiders
Open-market trades in the last 12 months
About Paul T Quinlan's insider trades
Paul T Quinlan is General Counsel at Oruka Therapeutics (ORKA). Since Jan 12, 2012, Paul has reported no open-market purchases and 55 sales worth $10.7M on SEC Form 4. In the last 12 months: 6 sales ($7.5M).
Their filings also include option exercises (36 filings), grants and awards (18 filings), shares returned to the company (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORKA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.